Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

RIOPAN CHEWABLE TABLETS 480MG DIN 02043564

Status: Cancelled Post Market
Holder: WYETH-AYERST CANADA INC.
Molecule: MAGALDRATE

Health Canada record

Active ingredient(s)MAGALDRATE 480 MG
Dosage formTablet
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassHuman
ATCA02AD02 MAGALDRATE
Original market date31-Dec-1994
Current status date31-Jul-2002
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MAGALDRATE

DINProductCompanyFormStrengthStatus
02043572RIOPAN PLUS SUSWYETH-AYERST CANADA INC.SuspensionMAGALDRATE 480 MG; DIMETHICONE 20 MGCancelled Post Market
01929410RIOPAN PLUS SUSPENSIONWHITEHALL-ROBINS INC.SuspensionMAGALDRATE 96 MG; DIMETHICONE 4 MGCancelled Post Market
01929461RIOPAN PLUS TABLETSWHITEHALL-ROBINS INC.TabletMAGALDRATE 480 MG; DIMETHICONE 20 MGCancelled Post Market
01931067RIOPAN SUS 480MG/5MLWHITEHALL-ROBINS INC.SuspensionMAGALDRATE 480 MGCancelled Post Market
02043580RIOPAN SUSPENSION 480MG/5MLWYETH-AYERST CANADA INC.SuspensionMAGALDRATE 480 MGCancelled Post Market
01931059RIOPAN TAB 480MGWHITEHALL-ROBINS INC.TabletMAGALDRATE 480 MGCancelled Post Market

International API supply for MAGALDRATE

1 active FDA Drug Master Files.

Request a quote for RIOPAN CHEWABLE TABLETS 480MG

How to read a Canadian DIN record